Looking ahead, I think the COVID-19 pandemic will definitely test the resiliency of all industries and its M&A deal volumes. Because of the significant changes in regulatory, technological demands, and the economy, this will create opportunities for more attractive price points for companies looking to buy and grow inorganically. Also with incentivizing global supply chain repatriation, it will be interesting to see how this will push acquisitions to attain direct control. I do think that after we get into a state of control post Covid, we will see an interesting wave of M&A deals emerge.
